Big news! 🚀 We are thrilled to announce that our first joint publication by 11 SHARE-CTD doctoral students is officially out in @springernature.com "Supporting the Reanalysis and Reuse of Clinical Trial Data: a case study" This paper is the fruit of our very first Datathon in Göttingen. 🧵

Yesterday was the last day of our @sharectd.bsky.social Datathon 2 in Utrecth. Over the 1 week, 3 independent teams worked on the same research question: “Does esketamine have an impact on suicidality?”, using the same individual patient data shared by Johnson & Johnson on the The YODA repository.

@kahin-tai.bsky.social's excellent talk (delivered as part of the LORIER Webinar Series on Reproducibility and Meta-Research, in partnership with @sharectd.bsky.social, ResToRes Research integrity in biomedical research, OSIRIS, the @reproductible-fr.bsky.social and Embrace) is now online.

Some Chinese scholar never fails to amaze me. This single-authored systematic review claims disagreements were ‘resolved by consensus,’ which must have been an intense negotiation between Me, Myself, and I. The state of peer review these days is wild.

😃 to share this new @plos.org Medicine 📄 written in collaboration with the super cool @kahin-tai.bsky.social (from the super cool @sharectd.bsky.social doctoral network), Gérard Legoff, @annelelouarn.bsky.social & @synthymama.bsky.social.

How can ORCID make research assessment more meaningful? Join Marie Curie Alumni Association on 29 Oct to see ORCID + PEP-CV in action! 🔗 Register & learn more: https://linktr.ee/orcid_org #ORCIDintheWild #ResearchAssessment

A must read work from our network. 👍

Update on my ski accident. After a thorough and well-informed discussion with my physiotherapist and surgeon, we agreed to perform a Ligamentoplastie LCA aux ischio-jambiers sous anesthésie générale. French healthcare system is quite user-friendly, highlighted by the warmth of French people :D

🎉 Kudos to Giulia @giulia-varvar.bsky.social for her speed talk at "Printemps de la Recherche" last Tuesday! She presented about SHARE-CTD, and her project on re-analysis of pivotal trials in Oncology, to Irset’s 350+ pros. A great moment to showcase open science in medicine!🔬 #SHARECTD #OpenScience

Big day - my first PhD project officially kicks off!🚀 With the review team now on board, we‘re diving into how often RCTs that say they‘ll share data actually end up in IPD meta-analyses. Let’s see if intention leads to impact :D osf.io/84wmx/

Welcome to the official Bluesky account of SHARE-CTD! We're a European research network dedicated to enhancing clinical trial data sharing to advance medical research and the betterment of society. Learn more: share-ctd.eu #SHARECTD #OpenScience #DataSharing

New news story on website. "Zombie trials don't just die after retraction—they continue to pollute meta-analyses, shift effect sizes, and distort clinical guidelines. A new @bmj.com study reveals the measurable scale of this hidden contamination." restores.univ-rennes.fr/highlights/q...

👋, the RestoRes team is delighted to host the Embrace project on its website. While RestoRes focuses on describing challenges regarding research integrity in biomedical research, Embrace develops tools to enhance data sharing—an essential practice for trustworthy research. restores.univ-rennes.fr

New highlight in the RestoRes website: « The European Medicines Agency has published revised policies on competing interests »

Not always can I clinically relate myself to a medical literature. After a recent fun accident on the alps, I have been looking into the rehabilitation of ACL injury. There are so many studies and opinions out there, sometimes contradictory, which got me wondering - whose studies can I trust?